CompletedNCT03377166Updated Jan 11, 2019

Measuring Subjective Visual Vertical (SVV) Using a Smartphone Application

An interventional study of Bucket test and Smartphone-based evaluation of SVV in Subjective Visual Vertical, sponsored by Tel-Aviv Sourasky Medical Center. Completed at 1 site in Israel. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-11.

Sponsored by Tel-Aviv Sourasky Medical Center · Not applicable, Interventional, and Diagnostic

Phase: Not applicable
Study type: Interventional
Enrollment: 45
Allocation: Non-randomized
Ages: 18 Years and older
Sex: All

Study summary

A comparison between two methods evaluating SVV: Bucket Test and A smartphone-based test.

Conditions studied

Subjective Visual Vertical

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: All
Accepts healthy volunteers: Yes

Inclusion criteria

Vestibular Disorder

Exclusion criteria

Exclusion Criteria:

Chronic ear disease, Neurological disorder, s/p Ear surgery

Study design

Phase: Not applicable
Primary purpose: Diagnostic
Allocation: Non-randomized
Intervention model: Parallel assignment
Masking: None (open label)
Enrollment: 45 participants (actual)

Study arms

Active comparator
Vertigo
Participants with vestibular disorder
Diagnostic Test: Bucket test and Smartphone-based evaluation of SVV
Active comparator
Control
Participants without vestibular disorder
Diagnostic Test: Bucket test and Smartphone-based evaluation of SVV

Interventions

Diagnostic testBucket test and Smartphone-based evaluation of SVV
Bucket test and Smartphone-based evaluation of SVV

What researchers measure

Primary outcomes

Results of Bucket test Smartphone-based evaluation of SVV
Time frame: 5 minutes
Results of Smartphone-based evaluation of SVV
Time frame: 5 minutes

Study locations

1 site

The Tel Aviv Sourasky Medical Center
Tel Aviv, Israel

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Registry details

Key details

Study ID: NCT03377166
Lead sponsor: Tel-Aviv Sourasky Medical Center
Responsible party: michal roll (Director, Tel-Aviv Sourasky Medical Center) — Principal investigator
First posted: Dec 19, 2017
Start date: Jan 1, 2018
Primary completion: Dec 19, 2018
Completion: Dec 19, 2018
Last update: Jan 11, 2019

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Tel-Aviv Sourasky Medical Center

Start the discussion